Needham & Company Reiterates Strong Buy on MiMedx Group (MDXG) Following 2Q Results
Tweet Send to a Friend
Needham & Company reiterated a Strong Buy rating and $20.00 price target on MiMedx Group (NASDAQ: MDXG) following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
